IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral ...
Irvine-based medical device maker Axonics Modulation Technologies Inc. (Nasdaq: AXNX) saw its market value top $1 billion in late June, after the FDA said it was safe for trial patients using its ...
Barely a month after winning FDA clearance for its long-lasting implant to treat bladder dysfunction, Axonics is wasting no time in bringing the device to the masses. The Southern California-based ...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable sacral ...
IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...
Now in July, the FDA approved our implantable device for full-body MRI scans with a 3 Tesla MRI scanner. With this incremental labeling approval, the Axonics devices MRI compatible for both 1.5T and ...
The race to treat a number of health conditions using neurostimulation technology is a marathon, not a sprint—but Medtronic and Axonics Modulation Technologies are still aiming for a photo finish. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results